Clinical trial
Interleukin-5 Receptor Expression in COPD
NCT03984799 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interleukin-5 Receptor Expression in COPD
- Lead sponsor
- University of Virginia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 21, 2020
- Completion date
- April 30, 2022
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd